Global Newswire by Notified: M&A

JULY 31, 2023

July 31, 2023 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that its subsidiary, Blast Asset Acquisition LLC, completed its acquisition of substantially all of the assets of Vital Pharmaceuticals, Inc. CORONA, Calif.,

Acquisitions 75

Acquisitions Pharmaceutical Corporation IT 75

Global Newswire by Notified: M&A

JULY 19, 2023

Ltd (“IPK”) (the “Transaction”).

Pharmaceutical 40

Pharmaceutical IT Business Corporation 40

Peak Frameworks

SEPTEMBER 19, 2023

In the world of finance and corporate responsibility, two terms frequently arise: "stakeholder" and "shareholder." A shareholder is an individual or entity that owns shares or stock in a corporation. What is a Shareholder? By virtue of their ownership, they possess a direct financial interest in the company's success.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

Devensoft

MAY 25, 2023

Corporate restructuring can be a game-changer for any organization, whether it’s a merger, acquisition, or any other strategic move. We, at Devensoft, help companies with their end-to-end M&A and have worked with several clients in the corporate sector to navigate this complex process.

Corporation 52

Corporation Mergers Mergers and Acquisitions Acquisitions 52

Global Newswire by Notified: M&A

DECEMBER 17, 2024

("IMCD" or "Company"), a global leading distribution and formulation partner of speciality chemicals and ingredients, has signed an agreement to acquire the personal care and pharmaceutical business of YCAM Corporation, a distributor based in South Korea ("YCAM").

Pharmaceutical 52

Pharmaceutical Business Corporation IT 52

Global Newswire by Notified: M&A

SEPTEMBER 12, 2023

12, 2023 (GLOBE NEWSWIRE) -- Valarie Ney , an experienced corporate and M&A attorney, has joined Hunton Andrews Kurth LLP as a partner in Washington, D.C. Ney represents clients from a broad array of industries, including the government contracting, pharmaceutical, healthcare, energy, technology and manufacturing sectors.

M&A 52

M&A Pharmaceutical Healthcare Manufacturing 52

Global Newswire by Notified: M&A

MARCH 5, 2024

Formed through the combination of two legacy animal health providers (Fujita Pharmaceutical Co. under the stewardship of ORIX Corporation, Sasaeah generates annual revenues of about €75 million, of which 50% from vaccines. and Kyoto Biken Laboratories Inc.)

Pharmaceutical 52

Pharmaceutical Manufacturing Portfolio Acquisitions 52

Global Newswire by Notified: M&A

JULY 16, 2023

Key companies covered in cannabis market are Aurora Cannabis, Aphria Inc, Canopy Growth Corporation, MedReleaf Corp., GW Pharmaceuticals. Tilray, and others Key companies covered in cannabis market are Aurora Cannabis, Aphria Inc, Canopy Growth Corporation, MedReleaf Corp., GW Pharmaceuticals. Cronos Group Inc.,

Pharmaceutical 40

Pharmaceutical Corporation 40

The Harvard Law School Forum

JUNE 16, 2023

Related research from the Program on Corporate Governance includes Are M&A Contract Clauses Value Relevant to Target and Bidder Shareholders? Flanagan are Partners and Hannah M. Brown is an Associate at Sidley Austin LLP. This post is based on their Sidley Austin memorandum. discussed on the Forum here ) by John C.

M&A 64

M&A Pharmaceutical Acquisitions Valuation 64

Global Newswire by Notified: M&A

JULY 19, 2023

Tokyo, Japan and Cambridge , UK, 20 July 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), will hold an investor and press conference on today’s announcement; “Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company.”

Investors 40

Investors Pharmaceutical Acquisitions Corporation 40

Global Newswire by Notified: M&A

MARCH 5, 2024

Issue du regroupement de deux acteurs historiques de la santé animale (Fujita Pharmaceutical Co. sous l'égide d'ORIX Corporation, Sasaeah génère des revenus annuels d'environ 75 millions d'euros, dont 50 % proviennent des vaccins. et Kyoto Biken Laboratories Inc.)

Pharmaceutical 40

Pharmaceutical Corporation 40

Shearman & Sterling

APRIL 3, 2018

Fundaro, No. 655205 (N.Y.

Business 52

Business Pharmaceutical Corporation 52

Shearman & Sterling

JANUARY 12, 2023

Travis Laster of the Delaware Court of Chancery denied a motion to dismiss claims as untimely in a derivative action brought by stockholders against the officers and directors of AmerisourceBergen Corporation (the "Company"). Lebanon County Employees' Retirement Fund v. Collis, C.A. 2021-1118-JTL (Del.

Pharmaceutical 52

Pharmaceutical Government Funds Corporation 52

Cooley M&A

OCTOBER 19, 2022

Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals. Lavoro to Become Publicly Traded Through Business Combination With TPB Acquisition Corporation I. DigitalOcean Agrees to Buy Cloudways. Sixth Street Invests in Blueprint Medicines. Notable public deals. Amazon to Acquire One Medical for $3.9

M&A 69

M&A Initial Public Offering Pharmaceutical Medical 69

The Harvard Law School Forum

JUNE 16, 2023

Related research from the Program on Corporate Governance includes Are M&A Contract Clauses Value Relevant to Target and Bidder Shareholders? Flanagan are Partners and Hannah M. Brown is an Associate at Sidley Austin LLP. This post is based on their Sidley Austin memorandum. discussed on the Forum here ) by John C.

M&A 40

M&A Pharmaceutical Acquisitions Valuation 40

The Risk Arbitrage Report

NOVEMBER 20, 2022

New Deals: • Indivior Plc Com (IZQVF) to acquire Opiant Pharmaceuticals Inc Com (OPNT). Washington Federal Inc Com (WAFD) to acquire Luther Burbank Corporation Com (LBC). First Community Bankshares Inc Com (FCBC) to acquire Surrey Bancorp Com (SRYB). Sh 11/15/22 (CSVI). Sh 11/15/22 (ECOM). Sh Cad 11/15/22 (NEXJF).

Pharmaceutical 40

Pharmaceutical Acquisitions Corporation Capital 40

OfficeHours

JANUARY 26, 2024

Veterinary pharmaceuticals firm Dechra Pharmaceuticals Plc , which EQT agreed to buy for around £4.5 “If you want to get a deal done in the first half, you had better be starting conversations with buyers in February.” billion ($5.7

Private Equity 130

Private Equity Equities Mergers and Acquisitions Investors 130

The Risk Arbitrage Report

SEPTEMBER 18, 2022

. • Potlatchdeltic Corporation Com Usd1 (PCH) completes acquisition of Catchmark Timber Trust Inc.230:1 Syros Pharmaceuticals Inc 1:10 R/S 9/19/22 87184Q206 (SYRS) completes acquisition of Tyme Technologies Inc.04382:1 230:1 Exc 9/15/22 737630103 (CTT). 9/15/22 (MANT). • Sh 9/16/22 (USAK). 04382:1 Exc 9/19/22 87184Q206 (TYME).

Pharmaceutical 40

Pharmaceutical Acquisitions Media Corporation 40

Shearman & Sterling

APRIL 3, 2018

Fundaro, No. 655205 (N.Y.

Business 40

Business Pharmaceutical Corporation 40

The New York Times: Mergers, Acquisitions and Dive

OCTOBER 16, 2023

The pharmacy chain, one of the country’s largest, faces more than a thousand lawsuits that say it filled illegal prescriptions for painkillers.

Sale 145

Sale IT Mergers and Acquisitions Pharmaceutical 145

Shearman & Sterling

JANUARY 12, 2023

Travis Laster of the Delaware Court of Chancery denied a motion to dismiss claims as untimely in a derivative action brought by stockholders against the officers and directors of AmerisourceBergen Corporation (the "Company"). Lebanon County Employees' Retirement Fund v. Collis, C.A. 2021-1118-JTL (Del.

Pharmaceutical 40

Pharmaceutical Government Funds Corporation 40

Peak Frameworks

AUGUST 15, 2023

By owning a share, they own a slice of the corporation, entitling them to a claim on a part of the company's assets and earnings. Roles of a Shareholder Shareholders are pivotal to a corporation and their decisions can significantly shape the direction of the company.

Shares 52

Shares Financial Statement Stock Corporation 52

M&A Leadership Council

MARCH 27, 2024

Jerry has conducted exercises and threat briefings for C-suite members, senior leadership, and boards of directors at top financial, energy, technology, retail, and pharmaceutical corporations, including 16 on the Fortune 50. Jerry earned his Bachelor of Science in Civil Engineering from Virginia Military Institute.

Advisory 52

Advisory Consulting Entertainment Pharmaceutical 52

How2Exit

MARCH 31, 2024

This episode serves as a deep dive into Patrick's journey from a young accounting graduate to a M&A powerhouse, navigating transactions in industries as varied as HVAC and pharmaceuticals. Yet, many smaller businesses shy away from this path due to perceived complexities or resources required to execute such a strategy successfully.

Business 130

Business Mergers and Acquisitions Securities M&A 130

Peak Frameworks

APRIL 29, 2024

This threat is pivotal for strategic planning, especially for professionals in finance, investment banking, and corporate finance sectors, as it directly impacts investment decisions and long-term profitability. Understanding this threat enables businesses to devise robust strategies to protect their market position.

Finance 52

Finance Finance Investment Banking Investment 52

Focus Investment Banking

OCTOBER 20, 2023

Washington, DC, (October 20, 2023) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that Bearing Distributors, Inc.

Investment Banking 52

Investment Banking Sale Banking Bank 52

Peak Frameworks

SEPTEMBER 12, 2023

A prime example is the pharmaceutical industry. Covering High Initial Costs or R&D Investments The initial stages of product development often involve high costs, especially in sectors like biotechnology, pharmaceuticals, and technology. Setting a High Initial Price Why would a company opt for a high initial price?

Pharmaceutical 52

Pharmaceutical Investment Banking Investment IT 52

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Mergers and Inquisitions

MAY 10, 2023

It’s safe, stable, low-tax, and light on corporate regulation – you can safely ignore the occasional executions of cannabis traffickers. Investment Banking in Singapore: Exit Opportunities The standard exit opportunities – private equity , hedge funds , and corporate development – are all available in Singapore, but everything is smaller.

Investment Banking 105

Investment Banking Banking Bank Investment 105

Devensoft

AUGUST 24, 2023

Mastering Operations, Cross-Selling, and Cost Efficiencies for Maximizing Value from Integrated Ventures The Power of Synergy and Value Creation Amidst the dynamic and fiercely competitive modern business arena, corporations continually strive to secure a distinct market advantage while fostering expansion.

Business 52

Business Collaboration Mergers and Acquisitions Management 52

M&A Leadership Council

SEPTEMBER 26, 2024

A strategic IMO Lead wouldn’t stop at Day 1 integration; they’d chart a multi-year plan for how the sales team’s merger contributes to larger corporate objectives, like boosting revenue in underperforming regions. The IMO Lead is responsible for ensuring that two distinct corporate cultures can co-exist—or better yet, blend.

Mergers and Acquisitions 52

Mergers and Acquisitions M&A Management Mergers 52

Mergers and Inquisitions

NOVEMBER 1, 2023

In terms of mobility , you could easily join a healthcare investment banking team , move to a portfolio company in a corporate development role, or potentially even move into venture capital if you’ve had some life sciences exposure. in biology. If you have an M.D.

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Growth Business

OCTOBER 2, 2023

US-based funds showed themselves to be vigorously interested in expanding European and UK businesses, while large corporates invested into growth companies as a means of outsourcing R&D and innovation – patterns which are expected to be sustained this year. Tim Bird is a corporate partner and a member of the VC practice at Fieldfisher.

Finance 52

Finance Finance Capital Funds 52

Growth Business

MARCH 26, 2025

Similarly, pharmaceutical giant Sandoz demonstrated how creating a psychologically safe environment boosted trust: during a six-week initiative focused on individual engagement, employee willingness to communicate openly increased by 12 per cent.

Business 52

Business Accountant IT Management 52

Cooley M&A

OCTOBER 24, 2024

Alexion Pharmaceuticals (Del. Alexion Pharmaceuticals , arose out of Alexion’s 2018 acquisition of a company called Syntimmune. As pandemic restrictions eased, Alexion deprioritized development of ALXN1830 in favor of shifting its resources toward other Alexion programs as part of a corporate goal to launch 10 products by 2023.

Mergers and Acquisitions 52

Mergers and Acquisitions Mergers Negotiation Sale 52

M&A Leadership Council

AUGUST 15, 2022

A sell-off, which is by far the most common type of divestiture (and the type usually referred to as such), is the sale of one or more company units to another company – for example, when BF Goodrich Corporation sold its JcAIR Test Systems business to Aeroflex Incorporated in 2005. What is a spin-off? .

Mergers and Acquisitions 40

Mergers and Acquisitions IPO M&A Initial Public Offering 40

Cooley M&A

JUNE 24, 2020

This relief-seeking exercise has been used regularly in our life sciences practice, where buyers have purchased or licensed single drug products or a line of drug products from large pharmaceutical sellers, who rarely maintain separate financials for those assets given the size of the assets compared to the overall size of the seller.

Financial Statement 40

Financial Statement Acquisitions Business IT 40